Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$13.42
At close: May 13, 7:00 AM EDT
$12.35
-1.07-7.97%
Pre-Market: May 13, 7:00 AM EDT
Comments
Loading...
Assembly Biosciences Analyst Ratings and Price Targets | NASDAQ:ASMB | Benzinga
Assembly Biosciences Inc has a consensus price target of $17.75 based on the ratings of 5 analysts. The high is $35 issued by Jefferies on September 20, 2024. The low is $2 issued by Truist Securities on October 24, 2022. The 3 most-recent analyst ratings were released by Guggenheim, Jefferies, and HC Wainwright & Co. on March 25, 2025, September 20, 2024, and March 24, 2023, respectively. With an average price target of $22.5 between Guggenheim, Jefferies, and HC Wainwright & Co., there's an implied 82.19% upside for Assembly Biosciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Guggenheim
Jefferies
Mizuho
Truist Securities
1calculated from analyst ratings
Analyst Ratings for Assembly Biosciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/25/2025 | Buy Now | 151.01% | Guggenheim | Vamil Divan73% | → $31 | Initiates | → Buy | Get Alert |
| 03/24/2025 | Buy Now | — | HC Wainwright & Co. | Ed Arce57% | — | Reiterates | Neutral → Neutral | Get Alert |
| 12/27/2024 | Buy Now | — | HC Wainwright & Co. | Ed Arce57% | — | Reiterates | Neutral → Neutral | Get Alert |
| 09/24/2024 | Buy Now | — | HC Wainwright & Co. | Ed Arce57% | — | Reiterates | → Neutral | Get Alert |
| 09/20/2024 | Buy Now | 183.4% | Jefferies | Dennis Ding16% | $2 → $35 | Upgrade | Hold → Buy | Get Alert |
| 06/20/2024 | Buy Now | — | HC Wainwright & Co. | Ed Arce57% | — | Reiterates | → Neutral | Get Alert |
| 06/13/2024 | Buy Now | — | HC Wainwright & Co. | Ed Arce57% | — | Reiterates | → Neutral | Get Alert |
| 04/01/2024 | Buy Now | — | HC Wainwright & Co. | Ed Arce57% | — | Reiterates | → Neutral | Get Alert |
| 03/24/2023 | Buy Now | -87.85% | HC Wainwright & Co. | Ed Arce57% | $2.5 → $1.5 | Maintains | Neutral | Get Alert |
| 11/16/2022 | Buy Now | -75.71% | Mizuho | Salim Syed42% | $14 → $3 | Maintains | Buy | Get Alert |
| 10/24/2022 | Buy Now | -83.81% | Truist Securities | Nicole Germino39% | $11 → $2 | Downgrade | Buy → Hold | Get Alert |
FAQ
What is the target price for Assembly Biosciences (ASMB) stock?
The latest price target for Assembly Biosciences (NASDAQ:ASMB) was reported by Guggenheim on March 25, 2025. The analyst firm set a price target for $31.00 expecting ASMB to rise to within 12 months (a possible 151.01% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Assembly Biosciences (ASMB)?
The latest analyst rating for Assembly Biosciences (NASDAQ:ASMB) was provided by Guggenheim, and Assembly Biosciences initiated their buy rating.
When was the last upgrade for Assembly Biosciences (ASMB)?
The last upgrade for Assembly Biosciences Inc happened on September 20, 2024 when Jefferies raised their price target to $35. Jefferies previously had a hold for Assembly Biosciences Inc.
When was the last downgrade for Assembly Biosciences (ASMB)?
The last downgrade for Assembly Biosciences Inc happened on October 24, 2022 when Truist Securities changed their price target from $11 to $2 for Assembly Biosciences Inc.
When is the next analyst rating going to be posted or updated for Assembly Biosciences (ASMB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Assembly Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Assembly Biosciences was filed on March 25, 2025 so you should expect the next rating to be made available sometime around March 25, 2026.
Is the Analyst Rating Assembly Biosciences (ASMB) correct?
While ratings are subjective and will change, the latest Assembly Biosciences (ASMB) rating was a initiated with a price target of $0.00 to $31.00. The current price Assembly Biosciences (ASMB) is trading at is $12.35, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
